{"action":"elsewhere","city":"DUBLIN","companyRegistrationNumber":null,"conformityFlag":"CONFORMING","country":"IE","createdAt":"2012-11-01T05:00:00Z","entityCategory":"GENERAL","entityStatus":"ACTIVE","entitySubCategory":null,"expirationReason":null,"expiredAt":null,"family":{"children":[],"childrenTotal":0,"exceptions":[],"parents":[{"active":true,"country":"US","legalName":"REGENERON PHARMACEUTICALS, INC.","lei":"549300RCBFWIRX3HYQ56","relationshipTypes":["IS_DIRECTLY_CONSOLIDATED_BY","IS_ULTIMATELY_CONSOLIDATED_BY"]}]},"headquartersAddress":"ONE WARRINGTON PLACE","headquartersCity":"DUBLIN","headquartersCountry":"IE","headquartersPostalCode":"D02 HH27","headquartersRegion":"IE-D","lastUpdatedAt":"2025-12-09T14:41:18.447Z","legalAddress":"ONE WARRINGTON PLACE","legalFormAbbreviation":"DAC – (limited by shares)","legalFormCode":"LGWG","legalFormName":"Designated Activity Company","legalJurisdiction":"IE","legalName":"REGENERON IRELAND DESIGNATED ACTIVITY COMPANY","lei":"635400NABUOXXFAMHX81","managingLou":"213800WAVVOPS85N2205","managingLouName":"London Stock Exchange","managingLouWebsite":"https://www.lseg.com/LEI","nextRenewalAt":"2027-02-01T00:00:00Z","otherLegalForm":null,"postalCode":"D02 HH27","region":"IE-D","registeredAt":"2019-03-28T00:00:00Z","registrationAuthorityId":"RA000402","registrationAuthorityName":"Companies Register","registrationAuthorityWebsite":"http://www.cro.ie/","registrationNumber":"519550","registrationNumberFormatted":"519550","registrationStatus":"ISSUED","served":false,"successorLeis":[],"validationAuthorityEntityId":"519550","validationAuthorityId":"RA000402","validationAuthorityName":"Companies Register","validationSources":"FULLY_CORROBORATED"}